Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IAH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRHPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ING2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBKS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASEL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACOT13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IER5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBPF26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
XRCC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF330 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on